CDKN2B anticorps
Aperçu rapide pour CDKN2B anticorps (ABIN1449282)
Antigène
Voir toutes CDKN2B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- This antibody reacts with p15INK4b (15 kDa).
-
Réactivité croisée (Details)
- Species reactivity (tested):Human (HeLa, 293T, transfectant), does not react with Mouse (NIH/3T3, P3U1) and Rat (PC12, Rat1)
-
Purification
- Protein A agarose
-
Immunogène
- GST-full length human p15INK4b
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 50 % glycerol, pH 7.2. Contains no preservatives.
-
Agent conservateur
- Without preservative
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Upon receipt, store (in aliqouts) at -20 °C.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Autre désignation
- CDKN2B / p15INK4b
-
Sujet
- Progression through the G1 phase of the cell cycle is regulated in part by the D-type cyclin-dependent kinases, cdk4 and cdk6. p15INK4b is a specific inhibitor of cdk4/cdk6 and is periodically expressed during cell cycle. Induction of p15INK4b is important for TGFß-mediated cytostasis in epithelial cells but not in hematopoietic cells, it may act as an effector of TGF-ß mediated cell arrest.Synonyms: Cyclin-dependent kinase 4 inhibitor B, MTS2, Multiple tumor suppressor 2, p14-INK4b, p14INK4b, p15-INK4b
-
ID gène
- 1030
-
NCBI Accession
- NP_004927
-
UniProt
- P42772
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases
Antigène
-